Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Medivolve Inc. (MEDVF)

Compare
0.0020
0.0000
(0.00%)
At close: April 9 at 4:00:00 PM EDT
Loading Chart for MEDVF
  • Previous Close 0.0000
  • Open 0.0020
  • Bid 0.0020 x --
  • Ask 0.0070 x --
  • Day's Range 0.0020 - 0.0020
  • 52 Week Range 0.0020 - 0.0150
  • Volume 133
  • Avg. Volume 2,240
  • Market Cap (intraday) 54,038
  • Beta (5Y Monthly) 4.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0700
  • Earnings Date Apr 10, 2025 - Apr 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.

www.medivolve.ca

25

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEDVF

View More

Performance Overview: MEDVF

Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MEDVF
66.67%
S&P 500 (^GSPC)
7.22%

1-Year Return

MEDVF
86.67%
S&P 500 (^GSPC)
4.74%

3-Year Return

MEDVF
95.35%
S&P 500 (^GSPC)
21.58%

5-Year Return

MEDVF
99.63%
S&P 500 (^GSPC)
95.60%

Compare To: MEDVF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEDVF

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    54.04k

  • Enterprise Value

    941.84k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.09

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.49

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -22.74%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    902.03k

  • Net Income Avi to Common (ttm)

    -2.69M

  • Diluted EPS (ttm)

    -0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    400.6k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    11.71M

Research Analysis: MEDVF

View More

Company Insights: MEDVF

Research Reports: MEDVF

View More

People Also Watch